These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25175457)

  • 41. Nigrostriatal and Mesolimbic D
    Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
    J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism.
    Thibault D; Albert PR; Pineyro G; Trudeau LÉ
    J Biol Chem; 2011 Mar; 286(11):9174-84. PubMed ID: 21233215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptor-receptor interactions and their relevance for receptor diversity. Focus on neuropeptide/dopamine interactions.
    Fuxe K; Li XM; Tanganelli S; Hedlund P; O'Connor WT; Ferraro L; Ungerstedt U; Agnati LF
    Ann N Y Acad Sci; 1995 May; 757():365-76. PubMed ID: 7611694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurotensin activates GABAergic interneurons in the prefrontal cortex.
    Petrie KA; Schmidt D; Bubser M; Fadel J; Carraway RE; Deutch AY
    J Neurosci; 2005 Feb; 25(7):1629-36. PubMed ID: 15716398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurotensin, schizophrenia, and antipsychotic drug action.
    Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple Adenosine-Dopamine (A2A-D2 Like) Heteroreceptor Complexes in the Brain and Their Role in Schizophrenia.
    Borroto-Escuela DO; Ferraro L; Narvaez M; Tanganelli S; Beggiato S; Liu F; Rivera A; Fuxe K
    Cells; 2020 Apr; 9(5):. PubMed ID: 32349279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diversity and bias through dopamine D2R heteroreceptor complexes.
    Borroto-Escuela DO; Fuxe K
    Curr Opin Pharmacol; 2017 Feb; 32():16-22. PubMed ID: 27838588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia.
    Borroto-Escuela DO; Pintsuk J; Schäfer T; Friedland K; Ferraro L; Tanganelli S; Liu F; Fuxe K
    Ther Adv Psychopharmacol; 2016 Apr; 6(2):77-94. PubMed ID: 27141290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
    Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
    Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurotensin: A role in substance use disorder?
    Ferraro L; Tiozzo Fasiolo L; Beggiato S; Borelli AC; Pomierny-Chamiolo L; Frankowska M; Antonelli T; Tomasini MC; Fuxe K; Filip M
    J Psychopharmacol; 2016 Feb; 30(2):112-27. PubMed ID: 26755548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation.
    Souazé F; Forgez P
    Peptides; 2006 Oct; 27(10):2493-501. PubMed ID: 16889873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
    Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
    Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse. Involvement of dopaminergic mechanisms.
    Hanson GR; Singh N; Merchant K; Johnson M; Bush L; Gibb JW
    Ann N Y Acad Sci; 1992; 668():165-72. PubMed ID: 1361111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling.
    Lemos JC; Friend DM; Kaplan AR; Shin JH; Rubinstein M; Kravitz AV; Alvarez VA
    Neuron; 2016 May; 90(4):824-38. PubMed ID: 27196975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurotensin modulates central muscarinic receptors, an effect which does not involve the high-affinity neurotensin receptor (NTS1).
    Schneider PG; López Ordieres MG; Rodríguez de Lores Arnaiz G
    Regul Pept; 2010 Aug; 163(1-3):37-42. PubMed ID: 20403392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway.
    Hanson GR; Keefe KA
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):111-21. PubMed ID: 10095083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias.
    Antonelli T; Fuxe K; Agnati L; Mazzoni E; Tanganelli S; Tomasini MC; Ferraro L
    J Neurol Sci; 2006 Oct; 248(1-2):16-22. PubMed ID: 16765381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
    Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
    Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.